Lung Therapeutics

Acquisition, funding and merger involving Lung Therapeutics.

• Aileron Therapeutics has acquired Lung Therapeutics (posted on November 1 2023).

View the org chart displaying its 10 main executives

Most searched biographies at Lung Therapeutics

• Brian Windsor, Chief Executive Officer and Director
• Aaron Fletcher, Director
• Alan Musso, Board Member

Create your alert
to follow the executive moves at Lung Therapeutics.

Lung Therapeutics has 2,290 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Bruker has announced the acquisition of NanoString Technologies  (posted on May 13 2024).
• Aardvark Therapeutics has just announced a $85 Million fundraising (posted on May 12 2024).
• Bluejay Therapeutics has just announced a $182 Million fundraising (posted on May 12 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Carl Gordon - Director at Adicet Bio
• Vik Bajaj - Director at Interline Therapeutics

Learn more about the Biotechnology industry >

Press releases by Lung Therapeutics

• Aileron Therapeutics Announces Acquisition of Lung Therapeutics
• Expanded Access Policy

Social media about Lung Therapeutics

• Lung Therapeutics on Wikipedia, Google News & Yahoo Finance
• Lung Therapeutics on LinkedIn, Twitter & YouTube

Contact by email its executives including Brian Windsor

Call Lung Therapeutics at +1 737...

View the org chart

Register to receive your alert

Report an error